Navidea Biopharmaceuticals, Inc. (AMEX:NAVB) – Earnings Outlook For Navidea Biopharmaceutical

Navidea Biopharmaceutical (AMEX:NAVB) is set to give its latest quarterly earnings report on Wednesday, 2022-03-23. Here’s what investors need to know before the announcement.

Analysts estimate that Navidea Biopharmaceutical will report an earnings per share (EPS) of $-0.03.

Navidea Biopharmaceutical bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.03, which was followed by a 0.69% drop in the share price the next day.

Here’s a look at Navidea Biopharmaceutical’s past performance and the resulting price change:

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -0.11 -0.08 -0.08 -0.12
EPS Actual -0.08 -0.09 -0.12 -0.11
Price Change % -0.69% -4.71% -1.23% 0.97%

Stock Performance

Shares of Navidea Biopharmaceutical were trading at $0.88 as of March 21. Over the last 52-week period, shares are down 58.75%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Source link

Copyright © 2022 Billionaire Club Co LLC. All rights reserved

Loading the chat ...